Literature DB >> 29143706

Potential sensitivity of pork production situations aiming at high-quality products to the use of entire male pigs as an alternative to surgical castrates.

M Bonneau1, M Čandek-Potokar2, M Škrlep2, M Font-I-Furnols3, M Aluwé4, L Fontanesi5.   

Abstract

The perspective of a possible ban on surgical castration of male pigs in the EU is a real challenge for pork production systems aiming at (very) high-quality products. Information was collected from a total of 272 situations in 16 European countries, including 170 situations related to EU protected designations (Database of Origin & Registration (DOOR) database) and 102 other situations related to high-quality products or differentiated production systems, in order to evaluate their potential sensitivity to the use of entire male pigs along four dimensions: BT_Inc, likelihood of increased levels of boar taint compounds compared with conventional production of entire males; BT_Per, extent to which (some of) the associated pork product(s) are susceptible to perception of boar taint by consumers; FatQQ, likelihood that the quality of (some of) the related products is decreased due to the lower fat quantity and quality in entire males; Manag, increased likelihood of animal management and welfare problems compared with conventional production of entire males. Situations corresponding to EU protected designations (DOOR situations) were on average more sensitive to entire male production but 11% of the non-DOOR situations were highly potentially sensitive, whereas one-third of the DOOR situations had low potential sensitivity. In total, 37% of the situations where castration is not formally specified as mandatory exhibited high potential sensitivity to entire male production. Three main patterns of situations were identified via ascending hierarchical clustering. A first pattern including 31% of the DOOR situations and 74% of the other ones, had potentially no increased risk compared with conventional production of entire males. A second pattern including 28% of the DOOR situations and 16% of the other ones had a high, moderate and low potential sensitivity for FatQQ, BT_Inc and Manag, respectively. The third pattern including 41% of the DOOR situations and 11% of the other situations had high potential sensitivity for BT_Inc and FatQQ, associated with moderate to high sensitivity for Manag. The approach used to evaluate the sensitivity to entire male pig production from the limited information collected for this study has many limitations. More precise approaches using more specific information are needed to evaluate the actual sensitivity of individual situations to the use of entire male pigs. Still, the present study provides a first global insight on the capacity of European production systems aiming at high-quality products to use entire male pigs as an alternative to surgical castration.

Entities:  

Keywords:  castration; entire male; meat; pig; quality

Mesh:

Year:  2017        PMID: 29143706     DOI: 10.1017/S1751731117003044

Source DB:  PubMed          Journal:  Animal        ISSN: 1751-7311            Impact factor:   3.240


  3 in total

1.  Quality of Dry-Cured Ham from Entire, Surgically and Immunocastrated Males: Case Study on Kraški Pršut.

Authors:  Marjeta Čandek-Potokar; Martin Škrlep; Eliza Kostyra; Sylwia Żakowska-Biemans; Klavdija Poklukar; Nina Batorek-Lukač; Kevin Kress; Ulrike Weiler; Volker Stefanski
Journal:  Animals (Basel)       Date:  2020-02-03       Impact factor: 2.752

2.  Influence of Housing Conditions on Reliability of Immunocastration and Consequences for Growth Performance of Male Pigs.

Authors:  Kevin Kress; Ulrike Weiler; Sonja Schmucker; Marjeta Čandek-Potokar; Milka Vrecl; Gregor Fazarinc; Martin Škrlep; Nina Batorek-Lukač; Volker Stefanski
Journal:  Animals (Basel)       Date:  2019-12-21       Impact factor: 2.752

Review 3.  Pros and Cons of Alternatives to Piglet Castration: Welfare, Boar Taint, and Other Meat Quality Traits.

Authors:  Michel Bonneau; Ulrike Weiler
Journal:  Animals (Basel)       Date:  2019-10-30       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.